Coste-efectividad de la oxigenoterapia de alto flujo en el tratamiento de la neumonía por SARS-CoV-2

INTRODUCTION: high-oxygen nasal cannulas in patients with respiratory failure secondary to SARS-CoV-2 pneumonia have not been studied from a cost-effectiveness point of view. METHODS: Retrospective analysis of patients who had entered the COVID-area of an intensive medicine service in a third refere...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Castro, A., Cuenca Fito, E., Fernandez, A., Peñasco, Y., Modesto i Alport, V., Medina Villanueva, A., Fajardo, A., Escude-Acha, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: FECA. Published by Elsevier España, S.L.U. 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595363/
https://www.ncbi.nlm.nih.gov/pubmed/36400703
http://dx.doi.org/10.1016/j.jhqr.2022.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595363/
https://www.ncbi.nlm.nih.gov/pubmed/36400703
http://dx.doi.org/10.1016/j.jhqr.2022.10.004

Ejemplares similares